Fair Value Calculator Fair Value Calculator
EN DE

CNCRD (CNCRD) Fair Value & Analysis

IN · Market cap ₹28.9B

C CNCRD CNCRD · BSE
Price₹2,859
Fair Value₹738.03
Upside-74.2%
Quality51/100
Watch CNCRD for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹544.31 – ₹1,300

Fair value as of: Jul 5, 2026

From 15 valuation models · updated today

Share price −2.7% over the past month.

Price vs Fair Value (12 months)

₹3,018 ₹1,038 Fair Value ₹738.03 Jul 2025 Jul 2026

12‑month range ₹1,038 – ₹3,018 · fair‑value band ₹544.31 – ₹1,300 · the ₹2,859 price screens above the ₹738.03 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

CNCRD (CNCRD) currently trades at ₹2,859, while our model-based Fair Value estimate is ₹738.03 — implying the stock looks roughly 74.2% overvalued today. We read business quality at 51/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, CNCRD generated revenue of ₹2.1B at a net margin of 20.1%. Revenue grew 72.6% year over year. It earns a return on equity of 25.6%. Net debt stands at ₹373M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹544.31 (bear case) to ₹1,300 (bull case); at ₹2,859, the current price sits above that range. The share trades about 7% below its 52-week high and 186% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹2.1B
Revenue growth (YoY) +72.6%
Net margin 20.1%
Return on equity 25.6%
Free cash flow −₹641M FY2026
P/E ratio 68.5
More key figures
Operating margin 27.9%
EPS (TTM) ₹41.74
EPS growth (YoY) +86.4%
Net debt ₹373M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

CNCRD reported revenue of ₹2.1B in FY2026 versus ₹315M in FY2022, a compound +60.8%/yr. Reported net income was ₹412M in FY2026, compounding +98.7%/yr from FY2022.

Revenue +60.8%/yr
FY22 ₹315M
FY23 ₹492M
FY24 ₹653M
FY25 ₹1.2B
FY26 ₹2.1B
Net income +98.7%/yr
FY22 ₹26.4M
FY23 ₹53.0M
FY24 ₹128M
FY25 ₹227M
FY26 ₹412M

Is CNCRD fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "CNCRD Fair Value". https://www.fairvalue-calculator.com/stock/CNCRD

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is CNCRD (CNCRD) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹738.03 versus a price of ₹2,859 — about −74% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CNCRD?
Our model-based fair value for CNCRD is ₹738.03 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹2,859.
What is the quality score of CNCRD?
CNCRD has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of CNCRD (CNCRD)?
CNCRD reported trailing-twelve-month revenue of about ₹2.1B (latest available figure, as of Jul 5, 2026).
What is the net profit margin of CNCRD?
The net profit margin of CNCRD is about 20.1%, meaning it keeps roughly 20.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.